Source: PR Newswire

Press Release: Histogen : Histogen Advances New Product Candidates Towards Clinical Trials

SAN DIEGO, Sept. 9, 2019 /PRNewswire/ -- Histogen, Inc., a regenerative medicine company with a unique biological platform that replaces and regenerates tissues in the body, today announced its plans for clinical development of three key product candidates during the Company's...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Richard Pascoe's photo - Chairman & CEO of Histogeninc

Chairman & CEO

Richard Pascoe

CEO Approval Rating

70/100

Read more